DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION DANAZOL IN API AND COMBINED DOSAGE FORM

In: World Journal of Pharmaceutical and life sciences · 2005 · vol. 2018 · W2982012250
article OA: closed CC0 ⤵ 2 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View on OpenAlex
AI-generated summary by claude@2026-06, 2026-06-08

This study developed and validated an RP-HPLC method for the simultaneous estimation of Danazol in both its Active Pharmaceutical Ingredient (API) and a combined dosage form.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (2)

Cited by (2)

Source provenance

openalex
last seen: 2026-05-10T10:08:28.574868+00:00
License: CC0 · commercial use OK